<DOC>
	<DOCNO>NCT01800812</DOCNO>
	<brief_summary>Methods Patients receive OM-174 twice weekly total 5 , 10 15 injection either 600 , 800 1000 µg/m² . Pharmacokinetic analysis cytokine dosage perform . Natural Killer cell activity toll-like receptor 4 polymorphism analysis also perform .</brief_summary>
	<brief_title>Effects OM-174 Adult Patients With Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Patient histologically proven solid tumor , refractory conventional treatment treatment exist . At least one month since last chemotherapy Life expectancy 3 month Written inform consent Age 18 Patient 's refusal Infection Brain metastasis Autoimmune disease Regular use steroid Patient include another protocol Chemotherapy radiotherapy le 6 week ago Immunotherapy le 8 week ago</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>